Navigating Treatment Options for Breast Cancer Patients

This chapter explores the intricacies of treatment options for dual eligible breast cancer patients, focusing on ribociclib and abemaciclib and their unique side effects. It also discusses ongoing research efforts, like the TRADE trial, aimed at improving treatment tolerability and patient outcomes.